Residents’ podcast: Health‐related quality of life among non‐muscle‐invasive bladder cancer survivors: a population‐based study

/
Maria Uloko is a Urology Resident at the University of Minnesota Hospital. In this podcast she discusses a recent Article of the week: Health‐related quality of life among non‐muscle‐invasive bladder cancer survivors: a population‐based study Abstract Objective To examine the effect of non‐muscle‐invasive bladder cancer (NMIBC) diagnosis and treatment on survivors’ quality of life (QoL). Patients and Methods Of the 5979 patients with NMIBC diagnosed between 2010…

January 2020 – About the cover

/
The first Article of the Month for 2020 is from work carried out at Northumbria University in Newcastle, Norfolk and Norwich University Hospital, both in the UK, and James Cook University in Queensland, Australia (Exercise-induced reduction of ADT side-effects in newly diagnosed PCa patients beginning androgen‐deprivation therapy: a randomised controlled trial). The article discusses the benefits of exercise in improving quality of life and reducing cardiovascular events following treatment for…

90 years of BJU International

/
This blog marks the launch of the British Journal of Urology 90 years ago.  Since then the Journal has undergone many changes as urology and the publishing environment have changed. The first Editors outlined their vision in the Foreword of the first issue, which includes an introduction to the speciality, the locations and opening hours of Urology Clinics and a plea for peace: The British Journal of Urology Vol.1 1929 From the outset, the Editors placed emphasis on seeking collaboration…

IP4-CHRONOS is launched

/
IP4- CHRONOS is open! CHRONOS is a phase II randomised control trial, that will review the outcomes (including oncological, functional, quality of life and cost-effectiveness) of focal therapy against those from radical therapy, in men with newly diagnosed localised clinically significant prostate cancer.     All men newly diagnosed with low-intermediate risk prostate cancer, confined to the prostate, with a life expectancy of at least 10 years will be screened for eligibility.…

December 2019 – About the cover

/
The lead authors of this month's selected article (Three‐dimensional virtual imaging of renal tumours: a new tool to improve the accuracy of nephrometry scores) are from the University of Turin, Italy (UNITO). This university was founded in 1404 making it one of the oldest universities in the World. It has been through some turbulent times but more recently can claim three nobel prize winners: Salvador Luria, Renato Dulbecco and Rita Levi-Montalcini. The cover image shows the city of…

Residents’ podcast: NICE Guidance – Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia

/
Nikita Bhatt is a Specialist Trainee in Urology in the East of England Deanery and a BURST Committee member @BURSTUrology NICE Guidance – Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia Recommendations 1.1 The evidence on transurethral water jet ablation for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) raises no major safety concerns. The evidence on efficacy is limited in quantity. Therefore,…

Residents’ podcast: NICE Guidance – Prostate cancer: diagnosis and management

/
Mr Joseph Norris is a Specialty Registrar in Urology in the London Deanery. He is currently undertaking an MRC Doctoral Fellowship at UCL, under the supervision of Professor Mark Emberton. His research interest is prostate cancer that is inconspicuous on mpMRI. Joseph sits on the committee of the BURST Research Collaborative as the Treasurer and BSoT Representative. NICE Guidance – Prostate cancer: diagnosis and management Context Prostate cancer is the most common cancer in men,…
© 2019 BJU International. All Rights Reserved.